Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Name: Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
Published: 2025
License: Public Domain

French Innovative Leukemia Organisation · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

blastic plasmacytoid dendritic cell neoplasm (bpdcn), blastic plasmacytoid dendritic cell neoplasm, combination of venetoclax + tagraxofusp, composite complete remission, complete remission, evaluation of response, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Related documents